Actinoplanes utahensis

Actinoplanes utahensis
Scientific classification
Domain:	Bacteria
Phylum:	Actinobacteria
Class:	Actinobacteridae
Order:	Micromonosporales
Family:	Micromonosporaceae
Genus:	Actinoplanes
Species:	A. utahensis
Binomial name
	Actinoplanes utahensis; Couch 1963

Actinoplanes utahensis is a species of bacteria and a source of the drug acarbose, an alpha-glucosidase inhibitor used in the treatment of diabetes mellitus.

Description

A. utahensis are irregular in size and shape. They form sporangia which are 5 to 18 micrometers in diameter, and contain sopres arranged in irregular coils. A. utahensis are motile by way of a number of flagella at one end.[1]

History

A. utahensis was originally identified by John Couch from soils collected from Salt Lake City's Liberty Park as well as along U.S. Route 40 in Nevada.[2]

References

Vobis G, Schafer J, Kampfer P (14 September 2015). "Actinoplanes". In Whitman WB (ed.). Bergey's Manual of Systematics of Archaea and Bacteria. John Wiley & Sons. doi:10.1002/9781118960608.gbm00139.
"Some New Genera and Species of the Actinoplanaceae". Journal of the Elisha Mitchell Scientific Society. 79: 69. May 1963. Retrieved 15 October 2017.

External links

Type strain of Actinoplanes utahensis at BacDive - the Bacterial Diversity Metadatabase

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Bergey-1] Vobis G, Schafer J, Kampfer P (14 September 2015). "Actinoplanes". In Whitman WB (ed.). Bergey's Manual of Systematics of Archaea and Bacteria. John Wiley & Sons. doi:10.1002/9781118960608.gbm00139.

[2] "Some New Genera and Species of the Actinoplanaceae". Journal of the Elisha Mitchell Scientific Society. 79: 69. May 1963. Retrieved 15 October 2017.